| Year |
Citation |
Score |
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Kim EK, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.455 |
|
| 2014 |
Kim EJ, Bond MR, Love DC, Hanover JA. Chemical tools to explore nutrient-driven O-GlcNAc cycling. Critical Reviews in Biochemistry and Molecular Biology. 49: 327-42. PMID 25039763 DOI: 10.3109/10409238.2014.931338 |
0.761 |
|
| 2014 |
Kim EJ, Abramowitz LK, Bond MR, Love DC, Kang DW, Leucke HF, Kang DW, Ahn JS, Hanover JA. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors. Bioconjugate Chemistry. 25: 1025-30. PMID 24866374 DOI: 10.1021/Bc5001774 |
0.757 |
|
| 2013 |
Kim EJ, Kang DW, Leucke HF, Bond MR, Ghosh S, Love DC, Ahn JS, Kang DO, Hanover JA. Optimizing the selectivity of DIFO-based reagents for intracellular bioorthogonal applications. Carbohydrate Research. 377: 18-27. PMID 23770695 DOI: 10.1016/J.Carres.2013.05.014 |
0.673 |
|
| 2013 |
Kim EJ, Hanover JA. Enzymatic characterization of recombinant enzymes of O-GlcNAc cycling. Methods in Molecular Biology (Clifton, N.J.). 1022: 129-45. PMID 23765659 DOI: 10.1007/978-1-62703-465-4_11 |
0.68 |
|
| 2010 |
Kim EJ, Love DC, Darout E, Abdo M, Rempel B, Withers SG, Rablen PR, Hanover JA, Knapp S. OGA inhibition by GlcNAc-selenazoline. Bioorganic & Medicinal Chemistry. 18: 7058-64. PMID 20822912 DOI: 10.1016/J.Bmc.2010.08.010 |
0.701 |
|
| 2008 |
Hajduch J, Nam G, Kim EJ, Fröhlich R, Hanover JA, Kirk KL. A convenient synthesis of the C-1-phosphonate analogue of UDP-GlcNAc and its evaluation as an inhibitor of O-linked GlcNAc transferase (OGT). Carbohydrate Research. 343: 189-95. PMID 18039537 DOI: 10.1016/J.Carres.2007.10.027 |
0.543 |
|
| 2007 |
Kim EJ, Amorelli B, Abdo M, Thomas CJ, Love DC, Knapp S, Hanover JA. Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. Journal of the American Chemical Society. 129: 14854-5. PMID 17994748 DOI: 10.1021/Ja076038U |
0.724 |
|
| 2007 |
Knapp S, Abdo M, Ajayi K, Huhn RA, Emge TJ, Kim EJ, Hanover JA. Tautomeric modification of GlcNAc-thiazoline. Organic Letters. 9: 2321-4. PMID 17508759 DOI: 10.1021/Ol0706814 |
0.581 |
|
| 2006 |
Forsythe ME, Love DC, Lazarus BD, Kim EJ, Prinz WA, Ashwell G, Krause MW, Hanover JA. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proceedings of the National Academy of Sciences of the United States of America. 103: 11952-7. PMID 16882729 DOI: 10.1073/Pnas.0601931103 |
0.74 |
|
| 2006 |
Kim EJ, Kang DO, Love DC, Hanover JA. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydrate Research. 341: 971-82. PMID 16584714 DOI: 10.1016/J.Carres.2006.03.004 |
0.746 |
|
| 2006 |
Kim EJ, Perreira M, Thomas CJ, Hanover JA. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety. Journal of the American Chemical Society. 128: 4234-5. PMID 16568991 DOI: 10.1021/Ja0582915 |
0.679 |
|
| 2006 |
Perreira M, Kim EJ, Thomas CJ, Hanover JA. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry. Bioorganic & Medicinal Chemistry. 14: 837-46. PMID 16214344 DOI: 10.1016/J.Bmc.2005.09.013 |
0.636 |
|
| 2003 |
Vocadlo DJ, Hang HC, Kim EJ, Hanover JA, Bertozzi CR. A chemical approach for identifying O-GlcNAc-modified proteins in cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 9116-21. PMID 12874386 DOI: 10.1073/Pnas.1632821100 |
0.667 |
|
| Show low-probability matches. |